JO
CALA

John Overdeck’s Calithera Biosciences, Inc CALA Stock Holding History

John Overdeck’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,947
Closed -$49K – 3017
2022
Q2 		$49K Sell
19,947
-22,327
-53% -$104K ﹤0.01% 2349
2022
Q1 		$342K Sell
42,274
-6,887
-14% -$70.4K ﹤0.01% 2169
2021
Q4 		$654K Buy
49,161
+39,145
+391% +$984K ﹤0.01% 2985
2021
Q3 		$437K Buy
10,016
+9,131
+1,032% +$394K ﹤0.01% 3370
2021
Q2 		$37K Sell
885
-3,365
-79% -$148K ﹤0.01% 3951
2021
Q1 		$206K Buy
4,250
+3,570
+525% +$208K ﹤0.01% 3616
2020
Q4 		$67K Sell
680
-9,359
-93% -$820K ﹤0.01% 3240
2020
Q3 		$693K Sell
10,039
-6,126
-38% -$535K ﹤0.01% 2006
2020
Q2 		$1.71M Buy
16,165
+11,904
+279% +$1.41M 0.01% 1180
2020
Q1 		$378K Sell
4,261
-2,873
-40% -$342K ﹤0.01% 2136
2019
Q4 		$815K Buy
7,134
+4,281
+150% +$322K ﹤0.01% 2381
2019
Q3 		$176K Sell
2,853
-1,237
-30% -$99K ﹤0.01% 3226
2019
Q2 		$319K Buy
4,090
+3,262
+394% +$370K ﹤0.01% 2832
2019
Q1 		$112K Sell
828
-1,336
-62% -$140K ﹤0.01% 2887
2018
Q4 		$174K Sell
2,164
-1,507
-41% -$149K ﹤0.01% 2739
2018
Q3 		$385K Buy
+3,671
New +$350K ﹤0.01% 2629
2018
Q1 		– Sell
-1,494
Closed -$250K – 3651
2017
Q4 		$250K Buy
+1,494
New +$383K ﹤0.01% 2817
2017
Q2 		– Sell
-687
Closed -$159K – 3388
2017
Q1 		$159K Buy
+687
New +$119K ﹤0.01% 2756

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

John Overdeck's CALA Position: Q3 2022 in Review

John Overdeck sold out of Calithera Biosciences, Inc (CALA) in Q3 2022, closing a stake of 19,947 shares — an estimated $49K sold.

John Overdeck first reported a position in CALA in Q1 2017 and held it in 18 quarters. The position peaked at $1.71M in Q2 2020. 22 funds tracked by Wall St. Rank hold CALA as of Q3 2022.

  • John Overdeck reported no remaining Calithera Biosciences, Inc position as of Q3 2022 after selling out during the quarter.
  • John Overdeck sold 19,947 Calithera Biosciences, Inc shares in Q3 2022, an estimated $49K.
  • John Overdeck first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 18 quarters.
  • John Overdeck's Calithera Biosciences, Inc position peaked at $1.71M in Q2 2020.
  • 22 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.